AI
The company claims that the testing solution checks the spectral signature of a virus from a nasal or mouthwash sample to detect COVID-19 within seconds.
The three-year partnership seeks to derive insights that can be applied to Otsuka's products and other offerings.
From drug discovery to forecasting kidney disease AI could be the next game-changer in healthcare.
The two South Korean tech firms have signed an agreement for AI integration.
Kheiron Medical Technologies will distribute its Mia, or “mammography intelligent assessment” in the GCC region via a new partnership with Atlas Medical.
They are also seeking ways to improve high blood pressure management.
The startup, known for its ring-type heart-monitoring device, recently raised $20 million in a Series B funding round.
KT will also open its digital healthcare platform for NeuroSigma's advanced monitoring and AI analysis services.
The model showed 86% sensitivity and a specificity of up to 96.1%.
The technology can detect 588 common and rare skin conditions in 133 categories.